School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Olumide Gbolahan

  • Department of Hematology and Medical Oncology
    Associate Professor
  • ogbolah@emory.edu
Head shot of Olumide Gbolahan

Overview

A board certified medical oncologist, Dr. Gbolahan specializes in the treatment of gastrointestinal cancers, particularly biliary tract, liver and pancreatic malignancies. Dr. Gbolahan joined the clinical staff at Winship Cancer Institute as a practicing physician in October 2021.

Dr. Gbolahan received his Medical Degree from University of Ibadan in Nigeria. His postgraduate medical education included residency training at Morehouse School of Medicine in Atlanta, Georgia. He completed his fellowship in hematology/oncology at Indiana University School of Medicine. He received his MSc in Cancer Immunology and Biotechnology from University of Nottingham.

Dr. Gbolahan's research focus is in early and late drug development and in translational research for hepatobiliary and pancreatic malignancies.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MBBS from University of Ibadan
  • MSc from University of Nottingham

Research

Publications

  • XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial.
    Oncoimmunology Volume: 14 Page(s): 2475620
    12/01/2025 Authors: Phillips MJ; Alese OB; Horvat NK; Greene E; Gbolahan OB; Coleman K; Doxie DB; Parihar V; Mahdi ZK; McCook-Veal A
  • A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations.
    Oncologist Volume: 30
    06/04/2025 Authors: Wheless MC; Zemla TJ; Hubbard JM; Strickler JH; Gbolahan OB; Wilson L; Waechter B; Ou F-S; Nixon AB; Bekaii-Saab TS
  • First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.
    Cancer Res Commun Volume: 5 Page(s): 896 - 905
    06/01/2025 Authors: Carneiro BA; Gbolahan OB; Abdul Razak AA; Hilton JF; Lambert AW; Hood J; Pluta M; Bragulat V; Sanai E; Kumar R
  • Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101.
    Future Oncol Volume: 21 Page(s): 1357 - 1363
    05/01/2025 Authors: Grewal US; Gbolahan OB; Takalkar AM; Halperin DM
  • Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell Anemia.
    Clin Nucl Med
    03/03/2025 Authors: Lawal IO; Gbolahan OB; Marcus C; Jones AT; Shaib WL; Muzahir S
  • A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.
    Endocr Relat Cancer Volume: 31
    10/01/2024 Authors: McDonald A; Avadhani V; Oprea-Ilies G; Zakka K; Lesinski GB; Gbolahan OB; Alese O
  • Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    JAMA Netw Open Volume: 7 Page(s): e2351502
    01/02/2024 Authors: Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
  • Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
    Curr Oncol Volume: 30 Page(s): 10100 - 10110
    11/25/2023 Authors: Villalobos A; Dabbous HH; Little O; Gbolahan OB; Akce M; Lilly MA; Bercu Z; Kokabi N
  • Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.
    Volume: 149 Page(s): 8673 - 8680
    09/01/2023 Authors: Sharma H; Moturi KR; Pankratz VS; Yilmaz E; Gbolahan OB; Kumar A; Hashemi-Sadraei N
  • Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
    Lancet Oncol Volume: 24 Page(s): 772 - 782
    07/01/2023 Authors: Harding JJ; Fan J; Oh D-Y; Choi HJ; Kim JW; Chang H-M; Bao L; Sun H-C; Macarulla T; Xie F
  • Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Volume: 401 Page(s): 1853 - 1865
    06/03/2023 Authors: Kelley RK; Ueno M; Yoo C; Finn RS; Furuse J; Ren Z; Yau T; Klmpen H-J; Chan SL; Ozaka M
  • Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
    Lancet Oncol Volume: 24 Page(s): 496 - 508
    05/01/2023 Authors: Strickler JH; Cercek A; Siena S; Andr T; Ng K; Van Cutsem E; Wu C; Paulson AS; Hubbard JM; Coveler AL
  • Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?
    J Surg Res Volume: 284 Page(s): 143 - 150
    04/01/2023 Authors: Fang HA; Irfan A; Vickers SM; Gbolahan O; Williams GR; Outlaw D; Wang TN-T; Dudeja V; Rose JB; Reddy S
  • Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.
    Cancer Med Volume: 12 Page(s): 3488 - 3498
    02/01/2023 Authors: Gbolahan O; Hashemi-Sadraei N; Yash S; Williams G; Ramachandran R; Kim Y-I; Paluri R; Outlaw D; El-Rayes B; Nabell L
  • Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018.
    Cancer Control Volume: 30 Page(s): 10732748231211764
    01/01/2023 Authors: Nghiem V; Wood S; Ramachandran R; Williams G; Outlaw D; Paluri R; Kim Y-I; Gbolahan O
  • Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies.
    J Am Geriatr Soc Volume: 71 Page(s): 136 - 144
    01/01/2023 Authors: Giri S; Al-Obaidi M; Harmon C; Clark D; Ubersax C; Dai C; Young-Smith C; Outlaw D; Gbolahan O; Khushman M
  • Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.
    JCO Oncol Pract Volume: 18 Page(s): e1796 - e1806
    11/01/2022 Authors: Arora S; Fowler ME; Harmon C; Al-Obaidi M; Outlaw D; Hollis R; Gbolahan O; Khushman M; Giri S; Williams GR
  • Geriatric Assessment Predictors of 1-Year Mortality in Older Adults With GI Malignancies: A Survival Tree Analysis.
    JCO Clin Cancer Inform Volume: 6 Page(s): e2200065
    09/01/2022 Authors: Williams GR; Dai C; Giri S; Al-Obaidi M; Harmon C; Kenzik KM; McDonald A; Gbolahan O; Outlaw D; Khushman M
  • Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?
    Am J Surg Volume: 224 Page(s): 955 - 958
    09/01/2022 Authors: Irfan A; Fang HA; Awad S; Alkashah A; Vickers SM; Gbolahan O; Williams GR; Nien-Tsu Wang T; Dudeja V; Rose JB
  • Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: Results from the CARE Registry.
    Cancer Volume: 128 Page(s): 2313 - 2319
    06/15/2022 Authors: Williams GR; Al-Obaidi M; Harmon C; Dai C; Outlaw D; Gbolahan O; Khushman M; Nyrop KA; Gilmore N; Bhatia S
  • A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors.
    Clin Transl Sci Volume: 15 Page(s): 1304 - 1315
    05/01/2022 Authors: Gbolahan OB; O'Neil BH; McRee AJ; Sanoff HK; Fallon JK; Smith PC; Ivanova A; Moore DT; Dumond J; Asher GN
  • Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer.
    Oncologist Volume: 27 Page(s): e45 - e52
    02/03/2022 Authors: Giri S; Mir N; Al-Obaidi M; Clark D; Kenzik KM; McDonald A; Young-Smith C; Paluri R; Nandagopal L; Gbolahan O
  • The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy.
    Pancreas Volume: 51 Page(s): 100 - 105
    01/01/2022 Authors: Irfan A; Rose JB; Wang TN; Vickers SM; Dudeja V; Gbolahan O; Reddy S
  • Fatigue is independently associated with functional status limitations in older adults with gastrointestinal malignancies-results from the CARE registry.
    Support Care Cancer Volume: 29 Page(s): 6793 - 6800
    11/01/2021 Authors: Williams GR; Al-Obaidi M; Dai C; Harmon C; Buford TW; Gbolahan O; Pergolotti M; Bhatia S; Giri S
  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
    J Natl Compr Canc Netw Volume: 19 Page(s): 1122 - 1132
    10/15/2021 Authors: Weiss JM; Gupta S; Burke CA; Axell L; Chen L-M; Chung DC; Clayback KM; Dallas S; Felder S; Gbolahan O
  • Gastric Sclerosing Epithelioid Fibrosarcoma Harboring a Rare FUS-CREM Fusion.
    Int J Surg Pathol Volume: 29 Page(s): 565 - 570
    08/01/2021 Authors: Memon RA; Granada CNP; Patel C; Manne U; Heslin MJ; Gbolahan OB; Harada S; Diffalha SA
  • Association Between Chronologic Age and Geriatric Assessment-Identified Impairments: Findings From the CARE Registry.
    J Natl Compr Canc Netw Volume: 19 Page(s): 922 - 927
    06/11/2021 Authors: Giri S; Al-Obaidi M; Weaver A; Kenzik KM; McDonald A; Clark D; Young-Smith C; Paluri R; Nandagopal L; Gbolahan O
  • Financial Distress Among Older Adults With Cancer.
    JCO Oncol Pract Volume: 17 Page(s): e764 - e773
    06/01/2021 Authors: Giri S; Clark D; Al-Obaidi M; Varnado W; Kumar S; Paluri R; Gbolahan O; Bhatia S; Williams GR
  • Depression among older adults with gastrointestinal malignancies.
    J Geriatr Oncol Volume: 12 Page(s): 599 - 604
    05/01/2021 Authors: Godby RC; Dai C; Al-Obaidi M; Giri S; Young-Smith C; Kenzik K; McDonald AM; Paluri RK; Gbolahan OB; Bhatia S
  • Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies.
    Cancer Volume: 126 Page(s): 5147 - 5155
    12/01/2020 Authors: Williams GR; Al-Obaidi M; Dai C; Mir N; Challa SA; Daniel M; Patel H; Barlow B; Young-Smith C; Gbolahan O
  • Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis- Results from the Cancer & Aging Resilience Evaluation (CARE) study.
    J Geriatr Oncol Volume: 11 Page(s): 982 - 988
    07/01/2020 Authors: Mir N; MacLennan P; Al-Obaidi M; Murdaugh D; Kenzik KM; McDonald A; Sharafeldin N; Young-Smith C; Paluri R; Gbolahan O
  • Geriatric assessment (GA) predictors of 1y mortality in older adults with gastrointestinal (GI) malignancies: Results from the CARE study.
    Volume: 38
    05/20/2020 Authors: Williams GR; Dai C; Al Obaidi M; Giri S; Kenzik K; McDonald AM; Smith CY; Gbolahan OB; Paluri RK; Richman J
  • Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE).
    J Geriatr Oncol Volume: 11 Page(s): 270 - 273
    03/01/2020 Authors: Williams GR; Kenzik KM; Parman M; Al-Obaidi M; Francisco L; Rocque GB; McDonald A; Paluri R; Navari RM; Nandagopal L
  • Depression among older adults with gastrointestinal (GI) malignancies: Results from the Cancer and Aging Resilience Evaluation (CARE) registry
    Volume: 38
    02/01/2020 Authors: Godby R; Al-Obaidi M; Smith CY; Kenzik K; McDonald AM; Paluri RK; Gbolahan OB; Bhatia S; Williams GR
  • Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia.
    Curr Cancer Drug Targets Volume: 20 Page(s): 473 - 489
    01/01/2020 Authors: Agrawal V; Gbolahan OB; Stahl M; Zeidan AM; Zaid MA; Farag SS; Konig H
  • Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic).
    Pan Afr Med J Volume: 36 Page(s): 153
    01/01/2020 Authors: Olabumuyi AA; Ali-Gombe M; Biyi-Olutunde OA; Gbolahan O; Iwuji CO; Joseph AO; Lasebikan NN; Ogunnorin BO; Omikunle AE; Salako O
  • Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience.
    Volume: 30 Suppl 4 Page(s): iv89
    07/01/2019 Authors: Jacob R; McDonald A; Manne U; Reddy S; Vickers S; Heslin M; Kyanam Kabir Baig K; Smith C; Williams G; Ali A
  • Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience.
    Volume: 30 Suppl 4 Page(s): iv74
    07/01/2019 Authors: Paluri R; Kasi A; Mcginnis T; Smith C; Williams G; Jacob R; Manne U; Gbolahan O; Naik G
  • Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer.
    Ann Oncol Volume: 30 Suppl 4 Page(s): iv67
    07/01/2019 Authors: Paluri R; Manne U; Williams G; Rose B; Heslin M; Reddy S; Kyanam Kabir Baig K; Vickers S; Ali A; Gbolahan O
  • Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
    J Natl Compr Canc Netw Volume: 17 Page(s): 644 - 648
    06/01/2019 Authors: Gbolahan O; Hashemi-Sadraei N; O'Neil B
  • Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    BMC Cancer Volume: 19 Page(s): 468
    05/17/2019 Authors: Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
  • Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX.
    Clin Cancer Res Volume: 24 Page(s): 6204 - 6211
    12/15/2018 Authors: Sehdev A; Gbolahan O; Hancock BA; Stanley M; Shahda S; Wan J; Wu HH; Radovich M; O'Neil BH
  • A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.
    J Thorac Oncol Volume: 13 Page(s): 1940 - 1948
    12/01/2018 Authors: Gbolahan OB; Porter RF; Salter JT; Yiannoutsos C; Burns M; Chiorean EG; Loehrer PJ
  • Improving communication with referring oncologists (RO): Indiana University experience.
    Volume: 36
    10/20/2018 Authors: Hashemi-Sadraei N; Kalra M; Gbolahan OB; Betbadal AM; Grethlein S
  • Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
    Am J Clin Oncol Volume: 41 Page(s): 982 - 985
    10/01/2018 Authors: Hashemi-Sadraei N; Gbolahan OB; Salfity H; O'Neil B; House MG; Shahda S
  • A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-MET co-expressing metastatic pancreatic adenocarcinoma.
    Volume: 36
    05/20/2018 Authors: Gbolahan OB; Sehdev A; Shahda S; Perkins S; Korc M; Loehrer PJ; O'Neil BH
  • Clinical features and survival outcomes in a prospective spontaneous regression (SR) protocol of renal cell carcinoma (RCC) and melanoma (M) patients
    Volume: 36
    05/20/2018 Authors: Gbolahan OB; Hashemi-Sadraei N; Conteh A; Kaimakliotis HZ; Storkus W; Pili R; Logan TF
  • Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.
    Int J Mol Sci Volume: 18
    07/31/2017 Authors: Gbolahan OB; Zeidan AM; Stahl M; Abu Zaid M; Farag S; Paczesny S; Konig H
  • Effect of chemotherapy on survival of patients with recurrent pancreatic ductal adenocarcinoma (PDAC) following surgical therapy.
    Volume: 35
    05/20/2017 Authors: Gbolahan OB; Tong Y; O'Neil BH; Shanda S
  • Locoregional and systemic therapy for hepatocellular carcinoma.
    J Gastrointest Oncol Volume: 8 Page(s): 215 - 228
    04/01/2017 Authors: Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
  • Re: Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
    J Natl Cancer Inst Volume: 106
    09/01/2014 Authors: Bakinde N; Gbolahan O; Ibraheem A
  • A CASE OF RENAL AMYLOIDOSIS WITHOUT MONOCLONAL GAMMOPATHY
    Volume: 63 Page(s): A48 - A48
    05/01/2014 Authors: Gbolahan O; Akinbobuyi O; Maihemuti A; Bashir K
  • Identification Of A Novel Region Of The Itgb6 Promoter Responsible For Basal Repression Of Itgb6 Transcription And Therefore av beta 6 Expression
    Volume: 189
    01/01/2014 Authors: Tatler AL; Goodwin A; Porte J; Gbolahan O; Clifford RL; Weinreb P; Violette S; Gauldie J; Kolb MRJ; Parfrey H
  • A PROSPECTIVE EVALUATION OF SERIAL LUNG FUNCTION IN A UK COHORT OF PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS (LAM)
    Volume: 67 Page(s): A49 - A49
    12/01/2012 Authors: Navaratnam V; Gbolahan O; Hubbard RB; Johnson SR
  • Road safety practices among commercial motorcyclists in a rural town in Nigeria: implications for health education.
    Int Q Community Health Educ Volume: 24 Page(s): 55 - 64
    01/01/2005 Authors: Amoran OE; Eme O; Giwa OA; Gbolahan OB
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements